Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

por Zerp, Shuraila F., Bibi, Zainab, Verbrugge, Inge, Voest, Emile E., Verheij, Marcel
Publicado en Clin Transl Radiat Oncol (2020)

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis

por Zerp, Shuraila F, Stoter, Rianne, Kuipers, Gitta, Yang, Dajun, Lippman, Marc E, van Blitterswijk, Wim J, Bartelink, Harry, Rooswinkel, Rogier, Lafleur, Vincent, Verheij, Marcel
Publicado 2009

Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

por Zerp, Shuraila F., Stoter, T. Rianne, Hoebers, Frank J. P., van den Brekel, Michiel W. M., Dubbelman, Ria, Kuipers, Gitta K., Lafleur, M. Vincent M., Slotman, Ben J., Verheij, Marcel
Publicado en Radiat Oncol (2015)